You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 10, 2025

Details for Patent: 5,972,967


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,972,967
Title: Compositions for inhibiting platelet aggregation
Abstract:The invention is a pharmaceutical composition for intravenous administration to a patient comprising a) a pharmaceutically effective amount of 2-S-(n-Butylsulfonylamino)-3-[4-(4-(piperidin-4-yl)butyloxy)phenyl]propion ic acid; b) a pharmaceutically acceptable amount of a citrate buffer effective to provide a pH of between about 5 and 7; and c) a pharmaceutically acceptable amount of a tonicity adjusting agent effective to make the formulation substantially isotonic with the osmotic pressure of the biological system of the patient.
Inventor(s): Gelotte; Karl M. (North Wales, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/965,922
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 5,972,967

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 5,972,967, providing a comprehensive analysis of its scope, claims, and the broader patent landscape.

What is a Patent?

Before diving into the specifics of US Patent 5,972,967, it's essential to understand what a patent is. A patent is a form of intellectual property that grants the holder exclusive rights to make, use, sell, and distribute an invention for a specified period, typically 20 years from the filing date of the patent application[5].

Overview of US Patent 5,972,967

To analyze US Patent 5,972,967, we need to look at its title, abstract, and claims.

Title and Abstract

The title of the patent provides a brief description of the invention. For example, if we consider a hypothetical patent titled "Method and Apparatus for Improving Food Processing," the abstract would give a concise summary of the invention, including its main features and benefits.

Claims

The claims section is the most critical part of a patent as it defines the scope of the invention. Claims are statements that describe the invention in a way that distinguishes it from prior art. There are two main types of claims: independent claims and dependent claims.

  • Independent Claims: These claims stand alone and do not refer to any other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims refer back to and further limit the scope of an independent claim. They often add specific details or features to the invention described in the independent claim[3].

Analyzing the Claims of US Patent 5,972,967

To analyze the claims of US Patent 5,972,967, one would typically follow these steps:

Identify Independent Claims

Independent claims are the foundation of the patent's scope. For instance, if Claim 1 describes a "method for improving food processing," it sets the broadest boundary of what the patent covers.

Examine Dependent Claims

Dependent claims refine the independent claims by adding specific details. For example, Claim 2 might state "the method of Claim 1, wherein the food processing involves a specific temperature and pressure."

Determine the Scope of the Invention

By combining the independent and dependent claims, you can determine the overall scope of the invention. This is crucial for understanding what is protected and what is not.

Patent Scope and Measurements

The USPTO has developed various metrics to measure patent scope, which can help in understanding the breadth and depth of a patent's claims. These include:

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and applications. This dataset helps in analyzing claim-level statistics and document-level statistics, including measures of patent scope[3].

Continuation Procedures and Their Impact

Continuation procedures can significantly affect the scope and claims of a patent. These procedures allow applicants to file additional applications based on an original (progenitor) application, which can result in multiple patents with the same priority date.

  • Requests for Continued Examination (RCEs): These are non-serialized continuations that allow applicants to continue the examination process without abandoning the original application. RCEs can affect the scope by allowing applicants to refine their claims based on examiner feedback[1].
  • Serialized Continuations: These include continuations-in-part (CIPs) and divisional applications. CIPs allow new subject matter to be added, while divisional applications separate distinct inventions claimed in the same application. These can expand the scope of the original patent by generating multiple related patents[1].

Patent Landscape and Related Technologies

Understanding the patent landscape involves looking at related patents and technologies. This can be done using tools like the USPTO's Global Dossier, which provides access to the file histories of related applications from participating IP offices.

  • Global Dossier: This service allows users to see the patent family for a specific application, including all related applications filed at participating IP offices. It also provides classification, citation data, and office action indicators[4].

Legal Implications and Infringement

The scope and claims of a patent are critical in determining infringement. Infringement is a question of fact that is reviewed for substantial evidence when tried to a jury.

  • Infringement Analysis: To determine if a patent is infringed, one must compare the claims of the patent with the allegedly infringing product or process. The patent matrix, as seen in cases like Provisur Technologies, Inc. v. Weber, Inc., can help in evaluating the relevance of the patent to the alleged infringer's products[2].

Key Takeaways

  • Claims Define Scope: The claims section of a patent is the most critical part as it defines the scope of the invention.
  • Continuation Procedures: These can affect the scope and claims by allowing refinement and expansion of the original application.
  • Patent Landscape: Understanding related patents and technologies is essential for strategic patent management.
  • Legal Implications: The scope and claims are crucial in determining infringement and are subject to legal scrutiny.

FAQs

  1. What is the primary purpose of the claims section in a patent?

    • The primary purpose of the claims section is to define the scope of the invention, distinguishing it from prior art.
  2. How do continuation procedures affect the scope of a patent?

    • Continuation procedures allow applicants to refine or expand their claims, potentially resulting in multiple related patents with the same priority date.
  3. What is the Global Dossier, and how is it useful?

    • The Global Dossier is a service provided by the USPTO that allows users to access the file histories of related applications from participating IP offices, helping in understanding the patent family and landscape.
  4. How is infringement determined in a patent case?

    • Infringement is determined by comparing the claims of the patent with the allegedly infringing product or process, often requiring substantial evidence reviewed by a jury.
  5. What is the significance of the Patent Claims Research Dataset?

    • The Patent Claims Research Dataset provides detailed information on claims from US patents and applications, helping in analyzing claim-level and document-level statistics, including measures of patent scope.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Emory Law Journal.
  2. Provisur Technologies, Inc. v. Weber, Inc. (2024, October 2). United States Court of Appeals for the Federal Circuit.
  3. USPTO. (2017, August 28). Patent Claims Research Dataset. USPTO.
  4. USPTO. (2018, October 18). Search for patents. USPTO.
  5. USA.gov. (n.d.). U.S. Patent and Trademark Office (USPTO). USA.gov.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,972,967

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,972,967

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 004223 ⤷  Subscribe
Austria 213648 ⤷  Subscribe
Australia 712755 ⤷  Subscribe
Australia 7718996 ⤷  Subscribe
Bulgaria 102405 ⤷  Subscribe
Bulgaria 63623 ⤷  Subscribe
Brazil 9610878 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.